Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants-Reference-Cited by-同舟云学术

Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants

Published:2006 Issue:11 Volume:45 Page:1041-1049
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Strehl Sabine,König Margit,Meyer Claus,Schneider Björn,Harbott Jochen,Jäger Ulrich,von Bergh Anne R. M.,Loncarevic Ivan F.,Jarosova Marie,Schmidt Helmut H.,Moore Steven D. P.,Marschalek Rolf,Haas Oskar A.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference55 articles.

1. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint

2. An ins(X;11)(q24;q23) fuses theMLLand theSeptin 6/KIAA0128gene in an infant with AML-M2

3. Analysis of canonical and non-canonical splice sites in mammalian genomes

4. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-existence of KMT2A::SEPTIN6 fusion and DIS3 variant in a pediatric case with acute myeloid leukemia: a case report and literature review;Frontiers in Oncology;2023-12-13

2. Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy;International Journal of Hematology;2023-06-14

3. Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma;Russian journal of hematology and transfusiology;2022-07-07

4. Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome;Leukemia Research Reports;2021

5. Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene;Leukemia & Lymphoma;2019-07-01